+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 110Years
All Genders
ID07635316

Observational Study on Treatment Patterns and Outcomes in Adults with Gastroenteropancreatic Neuroendocrine Tumors Using Real-World Claims Data

Led by Novartis Pharmaceuticals · Updated on 2026-10-15

4023

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying treatment patterns and clinical outcomes in adults newly diagnosed with gastroenteropancreatic neuroendocrine tumors GEP-NET in the United States. This observational study uses open-source prescription and medical claims data, along with mortality information, to understand how treatments are being used and their effects over time. The study is sponsored by Novartis Pharmaceuticals and aims to provide real-world insights into GEP-NET management. The study includes several patient groups based on the treatments they receive, such as first-line therapies with lutetium Lu 177 dotatate, CAPTEM capecitabine plus temozolomide, cabozantinib, and these treatments when given in second-line or later settings. Researchers will track the number of therapy lines, treatment regimens, therapy types, discontinuations, and treatment cycles over about eight years. No investigational drugs are administered directly as this is an observational study. Participants data will be reviewed for up to eight years to measure outcomes like time to treatment discontinuation, treatment switching, overall survival, and demographic and clinical characteristics. The study examines claims data before and after diagnosis and treatment initiation, focusing on real-world clinical outcomes. This long-term observation will help characterize treatment durations, switches, and survival outcomes among GEP-NET patients.

CONDITIONS

Brief Title

A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients

Research Team

N

Novartis Pharmaceuticals

N

Novartis Pharmaceuticals

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here